Advanced biomaterials for the Health Care (IA)
Closed
Status as published by the data source.
Expected Outcome:This topic refers to the innovation market for Healthcare and Medicine, which affects many citizens and their needs. Several materials specifications and related innovations needs will support this topic such as renewable and recyclable materials, alternative active ingredients, design for circularity, lightweight materials. The topic should address several key policies of the European Union such as Circular Economy Action Plan, EU Chemicals strategy.
Projects are expected to contribute to the following outcomes:
• Develop the swiftly growing innovation market of medical applications, which is dependent on advanced biocompatible materials that can be printed or injected, including 4D materials that change their 3D structures following external impact (e.g. thermic, electric, mechanical or radiation treatment).
• Medical and/or surgical procedures will benefit from injectable materials for non-invasive surgical procedures.
• Some of their advantages include easy deliverability into the body, increased implantation precision, controllable release of therapeutic agents, antimicrobial properties and the possibility of monitoring or stimulating biological events. Medical suppliers can commercialise injectable hydrogels, including those made of nanocomposite, natural and synthetic polymer-based biomaterials, bone cements, bio-ceramics and electronics.
Scope:Proposals should address at least four of the following activities:
• To enable a fast development of new advanced novel injectable biomaterials, digital tools such as modelling, simulation and characterisation techniques (including those provided by analytical infrastructures) assisted by advanced methods e.g. physics-based methods, machine learning or artificial intelligence.
• The innovation market of medical applications is fast growing and dependent on advanced biocompatible materials that can be printed or injected. The 4D materials will change their 3D structures after external impact such as thermic, electric, mechanical or radiation treatment.
• Proposals shall demonstrate new engineering strategies that present functional characteristics beyond bio-compatibility, and express properties that can be used to control the physiological environment (shape-memory, self-healing properties) and induce a response.
• Proposals shall address biomaterials with antibacterial properties contributing to the widespread bottleneck of antimicrobial resistance often encountered in clinical care
• Demonstrate the scaling of injectable hydrogels, including those made of nanocomposite, natural and synthetic polymer-based biomaterials, bone cements, bio-ceramics and electronics.
• The design for circularity has to develop, when relevant, bio-degradable or bio-absorbable biomaterials that are gradually eliminated by the body after fulfilling a purpose. The biomaterials used should be safe and sustainable by design (SSbD), taking also into account any specific medical requirements.
Proposals submitted under this topic should include a business case and exploitation strategy, as outlined in the introduction to this Destination.
This topic requires the effective contribution of SSH disciplines and the involvement of SSH experts, institutions as well as the inclusion of relevant SSH expertise, in order to produce meaningful and significant effects enhancing the societal impact of the related research activities. An early involvement of end users could be essential.
Projects should build on or seek collaboration with existing projects and develop synergies with other relevant European, national or regional initiatives, funding programmes and platforms.#
Where relevant, proposals should seek links with and capitalise on the results of past and ongoing EU funded research projects, including the ones under Cluster 1 “Health” and Cluster 6 'Food, Bioeconomy, Natural Resources, Agriculture and Environment.
- Status
- Closed
- Deadline
- (time not stated)
- Opens
- Published
- Total budget
- €31,000,000
- Grant range
- €6,000,000 – €8,000,000
- Country
- European Union (EU-wide)
- Programme
- Horizon Europe (HORIZON)
- Official page
- Open at the source portal
Other calls under Horizon Europe (HORIZON)
- PV based electrification of the economy: Designing & optimising PV systems supporting industrial electrification and promoting participation in electricity markets (EUPI-PV Partnership)
- Advanced TSO control rooms to enhance grid observability, stability and resilience
- Advanced Distribution Management Systems (ADSM) for more efficient and flexible distribution grids
- Community of practice - Data-Driven Decision-Making in Energy
- Industrial processes and equipment for innovative, reliable and scalable tandem technologies (EUPI-PV Partnership)
- Integrated Approaches for Retrofitting Infrastructures with Innovative Energy Storage Technologies
- Demonstration of hydropower technologies for efficient and forward-looking refurbishment of existing hydropower plants
- Delivery of industrial CCUS clusters – Societal Readiness pilot
All calls under this programme
Similar opportunities
- Circular innovative advanced materials: facilitating the transition from design to markets (RIA) (Innovative Advanced Materials for the EU and Made in Europe partnerships)
- Advancing bio-printing of living cells for regenerative medicine
- Innovative advanced materials and new production processes – reducing dependencies on Critical and Strategic Raw Materials (IA) (Innovative Advanced Materials for the EU and Processes4Planet partnerships)
- Supporting industry in the switch to sustainable and circular bio-based products and processes
- Advancing the European bio-based innovation enabled by biotechnology and biomanufacturing concepts
- Technologies for innovative processing of raw materials (IA)
Where this came from
- Source document
- https://ec.europa.eu/info/funding-tenders/opportunities/data/topicDetails/horizon-cl4-2024-resilience-01-36.json
- Document fingerprint
408f7b3ad5423a95(SHA-256, first 16 hex characters)- Retrieved
- First recorded here
What has changed
- deadline changed from 2024-09-23 to 2024-09-24 on
- url first recorded as https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/horizon-cl4-2024-resilience-01-36 on
- currency first recorded as EUR on
- amount_max first recorded as 8000000.00 on
- amount_min first recorded as 6000000.00 on
- budget_total first recorded as 31000000.00 on
- deadline first recorded as 2024-09-23 on
- opens_on first recorded as 2023-09-18 on
- published_on first recorded as 2022-12-06 on
- status_basis first recorded as source_status on
- status first recorded as closed on
- title first recorded as Advanced biomaterials for the Health Care (IA) on
Data source
© European Union, 2026. Source: EU Funding & Tenders Portal. Reused under Commission Decision 2011/833/EU — CC BY 4.0.
Retrieved from the source on .
The source last updated this document on Fri, 06 Jun 2025 09:37:56 GMT.
Personal data of natural persons has been dissociated by quiescence.eu.
This service is not affiliated with, sponsored or endorsed by the data publishers.